CVS Health (NYSE:CVS) updated its FY19 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus estimate of $6.84. CVS Health also updated its FY 2019 guidance to $6.89-7.00 EPS.
Several equities research analysts have issued reports on the stock. Morgan Stanley decreased their price target on shares of CVS Health from $92.00 to $74.00 and set an overweight rating on the stock in a research note on Monday, April 29th. BMO Capital Markets set a $63.00 price target on shares of CVS Health and gave the stock a hold rating in a research note on Friday, May 3rd. UBS Group decreased their price target on shares of CVS Health from $74.00 to $67.00 and set a sell rating on the stock in a research note on Thursday, May 2nd. Oppenheimer cut shares of CVS Health from an outperform rating to a market perform rating in a research note on Monday, April 15th. Finally, Raymond James decreased their price target on shares of CVS Health from $90.00 to $75.00 and set a strong-buy rating on the stock in a research note on Thursday, April 18th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of Buy and an average price target of $75.14.
Shares of CVS stock traded up $0.25 during trading hours on Friday, hitting $59.29. 5,977,933 shares of the company were exchanged, compared to its average volume of 9,059,762. The stock has a market cap of $75.50 billion, a price-to-earnings ratio of 8.37, a PEG ratio of 1.29 and a beta of 0.90. CVS Health has a 1 year low of $51.72 and a 1 year high of $82.15. The company has a debt-to-equity ratio of 1.45, a quick ratio of 0.64 and a current ratio of 0.95. The business’s fifty day moving average price is $55.66.
CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.70 by $0.19. The business had revenue of $63.43 billion for the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a net margin of 1.91% and a return on equity of 16.92%. The company’s revenue was up 35.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.69 EPS. As a group, equities research analysts predict that CVS Health will post 6.96 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were issued a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, July 24th. This represents a $2.00 annualized dividend and a yield of 3.37%. CVS Health’s payout ratio is 28.25%.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
See Also: Discount Rate
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.